Several states have lowered the threshold at which healthcare deals trigger regulatory review. Venable’s Ari Markenson explains the impact of these evolving transaction review laws.
A look at newly hired or promoted professionals across private equity firms, investment banks, private credit firms, and other middle-market M&A dealmakers and their partners